Adaptive Biotechnologies Corp. (Nasdaq: ADPT) announced on Tuesday it has begun enrolling a virtual clinical study, ImmuneRACE, as part of a broader effort it...
Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties






